The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (16.17) USD. With the latest stock price at 6.95 USD, the upside of Neogenomics Inc based on DCF is -332.7%.
Based on the latest price of 6.95 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 332.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.0% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (63.50) - (10.29) | (16.17) |
| Upside | -1013.6% - -248.1% | -332.7% |